These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8567111)

  • 1. Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas: association with the 150-kDa receptor form.
    Ness GO; Haugen DR; Varhaug JE; Akslen LA; Lillehaug JR
    Int J Cancer; 1996 Jan; 65(2):161-7. PubMed ID: 8567111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
    Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
    In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.
    Fluge O; Akslen LA; Haugen DR; Varhaug JE; Lillehaug JR
    Int J Cancer; 2000 Sep; 87(6):763-70. PubMed ID: 10956383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues.
    Marti U; Ruchti C; Kämpf J; Thomas GA; Williams ED; Peter HJ; Gerber H; Bürgi U
    Thyroid; 2001 Feb; 11(2):137-45. PubMed ID: 11288982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid.
    Scarpino S; Cancellario d'Alena F; Di Napoli A; Pasquini A; Marzullo A; Ruco LP
    J Pathol; 2004 Mar; 202(3):352-8. PubMed ID: 14991901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
    Kebebew E; Treseler PA; Duh QY; Clark OH
    Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met expression of thyroid tissue with special reference to papillary carcinoma.
    Oyama T; Ichimura E; Sano T; Kashiwabara K; Fukuda T; Nakajima T
    Pathol Int; 1998 Oct; 48(10):763-8. PubMed ID: 9788259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of genes encoding mitochondrial proteins in papillary thyroid carcinomas.
    Haugen DR; Fluge Ø; Reigstad LJ; Varhaug JE; Lillehaug JR
    Thyroid; 2003 Jul; 13(7):613-20. PubMed ID: 12964965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
    Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study.
    Rochaix P; Monteil-Onteniente S; Rochette-Egly C; Caratero C; Voigt JJ; Jozan S
    Histopathology; 1998 Oct; 33(4):337-43. PubMed ID: 9822923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.
    Gérard AC; Daumerie C; Mestdagh C; Gohy S; De Burbure C; Costagliola S; Miot F; Nollevaux MC; Denef JF; Rahier J; Franc B; De Vijlder JJ; Colin IM; Many MC
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4977-83. PubMed ID: 14557483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
    Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
    Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines.
    Reigstad LJ; Martinez A; Varhaug JE; Lillehaug JR
    Exp Cell Res; 2006 Apr; 312(6):782-95. PubMed ID: 16443219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Cancer Res; 1996 Mar; 56(6):1184-8. PubMed ID: 8640794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.